The Groningen-based high-tech company, QDI Systems, is receiving over € 5 million to further scale its ground-breaking quantum dot technology for both the medical sector and new markets. The funding round was led by NOM, along with previous investors Carduso Capital, RUG Ventures, and the renowned North European venture capital fund Maki.vc. In addition to private investment, the startup also receives an innovation credit from the Netherlands Enterprise Agency (RVO), thanks in part to the support of Enablemi, their partner in subsidy and innovation advice.
QDI Systems was founded in 2019 by CEO Artem Shulga. The company has developed sensor technology based on state-of-the-art nanomaterial: quantum dots. This material efficiently converts photons into electronic signals and has been widely used in imaging and sensor technology for the past few years.
The start-up is the world’s first company to apply quantum dots to X-ray machines. When quantum dots are used in X-ray examinations, they can provide higher image quality with much lower radiation doses. Therefore, the technology can have a significant impact on procedures such as mammography screening and diagnostics.
In-depth technical knowledge with commercial vision
During the Series A financing round, QDI Systems raised a total of € 3 million from investors such as NOM, Carduso Capital, RUG Ventures, and the Finnish deep tech fund Maki.vc.
“QDI Systems shows enormous potential to revolutionize medical imaging through the innovative use of quantum dot technology. The team has a unique scientific background, in-depth technical knowledge, and extensive commercial experience, providing a strong foundation for success,” says Ytsen van der Meer, Investment Manager at NOM.
“The ground-breaking application of quantum dot technology by QDI Systems sets new standards in medical imaging. We are excited to continue supporting Artem Shulga and his team in becoming the leading company in the industry,” says Paavo Räisänen, Partner at Maki.vc.
Read more on the RUG Ventures website
Any other questions? Reach out